GOTHENBURG, SWEDEN / ACCESSWIRE / July 12, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Second quarter 2024 (Apr 1 - Jun 30)…
Completed patient dosing in US Phase 3 clinical trials.There will be a two-year follow-up period, followed by submission of the…
Funded by a nearly £1.2M (~$1.5M USD) award, this research will enable ongoing validation of AccelADx™, a breakthrough screening test for…
Induced pluripotent stem cells are experiencing strong growth due to rising research into disease models and drug discovery. WILMINGTON, Del. ,…
HAUPPAUGE, N.Y., July 11, 2024 /PRNewswire/ -- An in-vitro study by Dr. A. Reza Kamarei, Dr. Howard F. Robins and…
NEW YORK, July 11, 2024 /PRNewswire/ -- ProofPilot, a leading Clinical Experience Platform (CXP), announced the closing of its Series…
SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry…
Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. Integrated AI and…
GUILDFORD, SURREY / ACCESSWIRE / July 11, 2024 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at…
CARDIFF, UK / ACCESSWIRE / July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a…